Endoscopic Response Reduces the Risk of Subsequent Pouchitis in Patients With Crohn's Disease-Like Pouch Inflammation.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 39207312.
- Also identified by DOI 10.14309/ajg.0000000000003055 and PMC identifier 11695146.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The aim of this study was to report the frequency and impact of endoscopic response and remission on the risk of subsequent pouchitis in patients with Crohn's disease-like pouch inflammation (CDLPI) on therapy. This was a single-center retrospective study of patients older than 18 years with CDLPI on therapy. Among 110 included patients with CDLPI in clinical remission, endoscopic remission was not significantly associated with a reduced risk of subsequent pouchitis when compared with endoscopic response. Endoscopic response, not remission, is sufficient to reduce the risk of subsequent pouchitis in patients with CDLPI.
Medical subject headings
- Pouchitis
- Crohn Disease